Óscar Millet

ORCID: 0000-0001-8748-4105 · 10 papers in corpus · active 2026

Study types

  • article 6
  • dataset 2
  • other 2
article 2026
·doi:10.6084/m9.figshare.32723643

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

article 2026
·doi:10.6084/m9.figshare.32723643.v1

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

dataset 2026
·doi:10.6084/m9.figshare.32723646.v1

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

dataset 2026
·doi:10.6084/m9.figshare.32723646

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

article 2026
·doi:10.6084/m9.figshare.32723652.v1

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
·doi:10.6084/m9.figshare.32723652

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
·doi:10.6084/m9.figshare.32723655.v1

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

article 2026
·doi:10.6084/m9.figshare.32723655

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

other 2026
·doi:10.6084/m9.figshare.c.8544015.v1

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…

other 2026
·doi:10.6084/m9.figshare.c.8544015

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…